China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026)
China Pharma Holdings' (CPHI) quarterly Prepaid Assets came in at $74279.0 in Q1 2026, down 9.93% YoY from $82469.0 in Q1 2025, and down 9.82% on a QoQ basis from $82368.0 in Q4 2025.
China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 13 years of Prepaid Assets data on file, last reported at $74279.0 in Q1 2026.
- Quarterly Prepaid Assets fell 9.93% year-over-year to $74279.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74279.0 (down 9.93% YoY) and the FY2025 annual result came in at $82368.0, up 1.28% from the prior year.
- Prepaid Assets slipped to $74279.0 in Q1 2026, from $82368.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $268498.0 in Q3 2023 to a low of $71788.0 in Q1 2022.
- A 5-year average of $107702.9 and a median of $87269.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 207.67% — and 2025, when it plunged 59.57%.
- Tracing CPHI's Prepaid Assets over 5 years: stood at $77697.0 in 2022, then jumped by 41.91% to $110258.0 in 2023, then slipped by 26.24% to $81328.0 in 2024, then increased by 1.28% to $82368.0 in 2025, then dropped by 9.82% to $74279.0 in 2026.
- The last three Prepaid Assets figures came in at $74279.0 (Q1 2026), $82368.0 (Q4 2025), and $75627.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | China Pharma Holdings | 42.13 Mn | 41.82 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,279.00 |
| Dec 31, 2025 | 82,368.00 |
| Sep 30, 2025 | 75,627.00 |
| Jun 30, 2025 | 74,869.00 |
| Mar 31, 2025 | 82,469.00 |
| Dec 31, 2024 | 81,328.00 |
| Sep 30, 2024 | 114,202.00 |
| Jun 30, 2024 | 115,610.00 |
| Mar 31, 2024 | 203,999.00 |
| Dec 31, 2023 | 110,258.00 |
| Sep 30, 2023 | 268,498.00 |
| Jun 30, 2023 | 117,979.00 |
| Mar 31, 2023 | 102,774.00 |
| Dec 31, 2022 | 77,697.00 |
| Sep 30, 2022 | 87,269.00 |
| Jun 30, 2022 | 89,935.00 |
| Mar 31, 2022 | 71,788.00 |
| Dec 31, 2021 | 58,792.00 |
| Sep 30, 2021 | 72,805.00 |
| Jun 30, 2021 | 54,034.00 |